Delivery Order SPE2DB20D3103-SPE2DB25FN9W4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Bicillin L-A 1,200,000 units in 2mL formulations, with a ceiling value of $1,443.54. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement from the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Bicillin L-A 1,200,000 units 2ML, an antibiotic pharmaceutical product. This firm fixed-price delivery order, valued at $4,330.62, is scheduled for completion by June 2, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating it was awarded through open competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Bicillin L-A 2,400,000 units in 4mL formulation, with a ceiling value of $16,936.62. This competitively awarded, firm fixed price delivery order is scheduled for ultimate completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the competitive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $77,951.16 to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 Units 2ML, a penicillin-based antibiotic pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award includes no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ML vials, with a ceiling value of $2,887.08. This competitive award, issued without a set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ML formulation, valued at $34,644.96. This competitively awarded, non-set-aside delivery order is classified as a firm fixed price contract with an ultimate completion date of June 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ML formulations, with a contract ceiling value of $2,887.08. This is a firm fixed price delivery order with no set-aside designation, reflecting open and competitive procurement. The order is scheduled for ultimate completion by May 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,535.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bicillin L-A 1,200,000 units in 2mL vials, with an ultimate completion date of May 5, 2025. This non-set-aside contract, awarded May 2, 2025, represents a direct purchase of pharmaceutical inventory to support federal healthcare operations. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $138,579.84 on June 2, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ML formulation. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date for this delivery order is June 3,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ml formulations, with a ceiling value of $1,831.46. This competitively awarded, non-set-aside contract is classified as a delivery order with firm fixed pricing and is scheduled for completion by May 7, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN9W4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Bicillin L-A 1,200,000 Units 2ML, an antibiotic pharmaceutical product. The contract is valued at $123,697.64 with firm fixed pricing and a completion date of May 30, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capacity to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains through open competition and firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $123.7k | 5/29/25 |